BUY Dalmia Bharat Ltd. — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)2 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
11 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·27 Oct · 2w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·25 Sept · 1mo ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · yesterday
Dalmia Bharat bears the brunt of weak demand, cost inflation in Q2
NewsLivemint·27 Oct · 2w ago
Dalmia Bharat shares hit 52-week low after Q2 results - Should investors buy, sell, or hold the stock? Experts take
NewsLivemint·27 Oct · 2w ago
Dalmia Bharat Shares Sink 6% As EBITDA Per Tonne Takes A Beating
NewsNdtv-Profit·27 Oct · 2w ago
Dalmia Bharat shares fall 6% on HSBC downgrade, multiple target cuts after Q2 results
NewsCnbc-Tv18·27 Oct · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Dalmia Bharat
- BUY — Jefferies India27 Oct 2026 · ~1 year · target ₹2,125 · Active
- BUY — Prakash Gaba16 Oct 2026 · ~2 weeks · target ₹1,750 · SL hit
- BUY — Emkay Global12 Oct 2026 · ~1 year · target ₹2,050 · Active
- BUY — HDFC Securities25 Sept 2026 · ~3 months · target ₹2,110 · Active
- BUY — Citigroup24 Sept 2026 · ~1 year · target ₹2,150 · Active
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

